The cost of drug development.

The Tufts Center for the Study of Drug Development designed the recent study of the costs of new drug research and development to capture only the costs incurred by industry, but typically R&D efforts in the private and public sectors are complements, not substitutes.

[1]  Henry G. Grabowski,et al.  R&D Costs and Returns by Therapeutic Category , 2004 .

[2]  H. Grabowski,et al.  Returns to R&D on new drug introductions in the 1980s. , 1994, Journal of health economics.

[3]  Donald W Light,et al.  Extraordinary claims require extraordinary evidence. , 2005, Journal of health economics.

[4]  Jerry Avorn,et al.  The $2.6 billion pill--methodologic and policy considerations. , 2015, The New England journal of medicine.

[5]  R. W. Hansen,et al.  The price of innovation: new estimates of drug development costs. , 2003, Journal of health economics.